Clinical Trials Browser

Phase 3 × Aclarubicin × 90 days × Clear all

NCT07541755 2026-04-21

PD1-VEN-CAG

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma